Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing

BACKGROUND: The COVID-19 pandemic has exacerbated the opioid crisis. Opioid-related deaths have increased and access to treatment services, including opioid agonist treatment (OAT), has been disrupted. The Ontario COVID-19 OAT Treatment Guidance document was developed to facilitate access to OAT and...

Descripción completa

Detalles Bibliográficos
Autores principales: Corace, Kim, Suschinsky, Kelly, Wyman, Jennifer, Leece, Pamela, Cragg, Sue, Konefal, Sarah, Pana, Priscille, Barrass, Susan, Porath, Amy, Hutton, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695187/
https://www.ncbi.nlm.nih.gov/pubmed/35123246
http://dx.doi.org/10.1016/j.drugpo.2021.103573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695187/
https://www.ncbi.nlm.nih.gov/pubmed/35123246
http://dx.doi.org/10.1016/j.drugpo.2021.103573

Ejemplares similares